Rip140 is Associated with Subclinical Inflammation in Type 2 Diabetic Patients

J. Xue,H. Zhao,G. Shang,R. Zou,Z. Dai,D. Zhou,Q. Huang,Y. Xu
DOI: https://doi.org/10.1055/s-0032-1323683
2013-01-01
Experimental and Clinical Endocrinology & Diabetes
Abstract:Aims: To evaluate the expression level of RIP140 (receptor interaction protein 140) and its correlation with inflammatory cytokine production and free fatty acids (FFAs) in type 2 diabetes.Methods: Plasma and peripheral blood mononuclear cells (PBMCs) were collected from 24 diabetic and 30 healthy individuals. The levels of FFAs, TC, TG, HDL-C, LDL-C, FIN, and FBG were measured. The insulin resistance index was calculated using the homeostasis model assessment (HOMA). Additionally, PBMCs from control group were cultured alone or with 500 mu mol/L palmitic acid (PA). Levels of RIP140 TNF-alpha, and IL-6 in PBMCs were analyzed using real-time RT-PCR, Western blots and ELISA. The relationship between RIP140 and other variables was performed using SPSS 11.5 software.Results: TG, LDL-C, FIN, FBG, HOMA, and HDL-C were significantly different between diabetic patients and the control group. Levels of RIP140, TNF-alpha, and IL-6 were higher in the diabetic group compared to control. RIP140 expression was positively correlated with FFAs, HDL-c, TNF-alpha, IL-6, FIN, FBG, and HOMA. Finally, 500 mu mol/L PA treatment increased RIP140 expression and the secretion of inflammatory cytokines in cultured control PBMCs.Conclusions: Increased RIP140 level may be closely associated with inflammation and disorder of lipid and glucose metabolism in diabetic patients.
What problem does this paper attempt to address?